Colorectal Cancer
Tizona Therapeutics Expands Phase Ib Trial to Include Biomarker-Selected Colorectal Cancer Cohorts
In the new arms, patients with certain biomarker-defined tumors will receive either an HLA-G targeted antibody, chemo, and Erbitux, or just chemo and Erbitux.
Alloplex Biotherapeutics Plans Phase II Cell Therapy Trial in Colorectal Cancer
Following encouraging results from a first-in-human clinical trial, the firm plans to submit an IND application to start a Phase II trial.
Transgender Patients With Hereditary Cancer Risk Variants Benefit From Individualized Approach
Premium
Doctors are using limited guidance on screening and treatment approaches for transgender patients predisposed to cancer while considering patient preferences and treatment goals.
Exact Sciences Nabs FDA Approval for Cologuard Plus Assay
The stool-based test is the next-generation version of Exact's existing Cologuard test for colorectal cancer screening.
BioAI, Arbele Team up to Develop AI-Based Biomarker Screening Test
The companies will initially develop an AI-based test to select patients with CDH17-expressing gastrointestinal cancers for Arbele's Phase I drug trial.